| [1] | 中华医学会儿科学分会内分泌遗传代谢学组. 儿童单基因糖尿病临床诊断与治疗专家共识[J]. 中华儿科杂志, 2019, 57(7): 508-514. | 
																													
																						| [2] | Lemelman MB, Letourneau L, Greeley SAW. Neonatal diabetes mellitus: an update on diagnosis and management[J]. Clin Perinatol, 2018, 45(1): 41-59. doi: 10.1016/j.clp.2017.10.006
 | 
																													
																						| [3] | Hattersley AT, Greeley SAW, Polak M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents[J]. Pediatr Diabetes, 2018, 19 Suppl 27: 47-63. doi: 10.1111/pedi.12772
																																					pmid: 30225972
 | 
																													
																						| [4] | Barbetti F, D'Annunzio G. Genetic causes and treatment of neonatal diabetes and early childhood diabetes[J]. Best Pract Res Clin Endocrinol Metab, 2018, 32(4): 575-591. doi: 10.1016/j.beem.2018.06.008
 | 
																													
																						| [5] | Rabbone I, Barbetti F, Gentilella R, et al. Insulin therapy in neonatal diabetes mellitus: a review of the literature[J]. Diabetes Res Clin Pract, 2017, 129: 126-135. doi: 10.1016/j.diabres.2017.04.007
 | 
																													
																						| [6] | Yahaya TO, Anyebe DA. Genes predisposing to neonatal diabetes mellitus and pathophysiology: Current findings[J]. J Neonatal Perinatal Med, 2020, 13(4): 543-553. doi: 10.3233/NPM-190353
 | 
																													
																						| [7] | Letourneau LR, Carmody D, Wroblewski K, et al. Diabetes presentation in infancy: High risk of diabetic ketoacidosis[J]. Diabetes Care, 2017, 40(10): e147-e148. doi: 10.2337/dc17-1145
 | 
																													
																						| [8] | 章淼滢, 罗飞宏. 儿童单基因糖尿病诊治进展及诊断策略[J]. 诊断学理论与实践, 2021, 20(3): 229-233. | 
																													
																						| [9] | Temple I K, Shield J P. Transient neonatal diabetes, a disorder of imprinting[J]. J Med Genet, 2002, 39(12): 872-875. pmid: 12471198
 | 
																													
																						| [10] | Beltrand J, Busiah K, Vaivre-Douret L, et al. Neonatal diabetes mellitus[J]. Front Pediatr, 2020, 8: 540718. doi: 10.3389/fped.2020.540718
 | 
																													
																						| [11] | Du Y T, Moore L, Poplawski N K, et al. Familial GATA6 mutation causing variably expressed diabetes mellitus and cardiac and renal abnormalities[J]. Endocrinol Diabetes Metab Case Rep, 2019, 2019: 19-0022. | 
																													
																						| [12] | 朱琼, 袁珂, 王春林, 等. FOXP3基因突变致X连锁多内分泌腺病肠病伴免疫失调综合征二例[J]. 中华医学遗传学杂志, 2018, 35(3): 389-392. | 
																													
																						| [13] | Busiah K, Auger J, Fauret-Amsellem AL, et al. Differentiating transient idiopathic hyperglycaemia and neonatal diabetes mellitus in preterm infants[J]. Horm Res Paediatr, 2015, 84(1): 68-72. doi: 10.1159/000381621
 | 
																													
																						| [14] | Zhang H, Zhong X, Huang Z, et al. Sulfonylurea for the treatment of neonatal diabetes owing to KATP-channel mutations: a systematic review and meta-analysis[J]. Oncotarget, 2017, 8(64): 108274-108285. doi: 10.18632/oncotarget.22548
 | 
																													
																						| [15] | 中华医学会儿科学分会内分泌遗传代谢学组,《中华儿科杂志》编辑委员会. 儿童及青少年糖尿病的胰岛素治疗指南(2010年版)[J]. 中华儿科杂志, 2010, 48(6): 431-435. | 
																													
																						| [16] | Babiker T, Vedovato N, Patel K, et al. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes[J]. Diabetologia, 2016, 59(6): 1162-1166. doi: 10.1007/s00125-016-3921-8
																																					pmid: 27033559
 | 
																													
																						| [17] | Bowman P, Sulen Å, Barbetti F, et al. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study[J]. Lancet Diabetes Endocrinol, 2018, 6(8): 637-646. doi: 10.1016/S2213-8587(18)30106-2
 | 
																													
																						| [18] | Li X, Cheng Q, Ding Y, et al. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report[J]. BMC Pediatr, 2019, 19(1): 233. doi: 10.1186/s12887-019-1608-2
 | 
																													
																						| [19] | Yeung RO, Hannah-Shmouni F, Niederhoffer K, et al. Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes[J]. Rev Endocr Metab Disord, 2018, 19(1): 35-52. doi: 10.1007/s11154-018-9446-3
 | 
																													
																						| [20] | Ben-Skowronek I. IPEX Syndrome: Genetics and Treatment Options[J]. Genes (Basel), 2021, 12(3): 323. doi: 10.3390/genes12030323
 | 
																													
																						| [21] | Burroughs L M, Torgerson T R, Storb R, et al. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome[J]. J Allergy Clin Immunol, 2010, 126(5): 1000-1005. doi: 10.1016/j.jaci.2010.05.021
																																					pmid: 20643476
 | 
																													
																						| [22] | Chen S, Du K, Zou C. Current progress in stem cell therapy for type 1 diabetes mellitus[J]. Stem Cell Res Ther, 2020, 11(1): 275. doi: 10.1186/s13287-020-01793-6
 | 
																													
																						| [23] | London S, De Franco E, Elias-Assad G, et al. Case report: neonatal diabetes mellitus caused by a novel GLIS3 mutation in twins[J]. Front Endocrinol (Lausanne), 2021, 12: 673755. doi: 10.3389/fendo.2021.673755
 |